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Over the last 2 decades, a large number of neurophysiolog-
ical and neuroimaging studies of patients with schizophre-
nia have furnished in vivo evidence for dysconnectivity, ie,
abnormal functional integration of brain processes. While
the evidence for dysconnectivity in schizophrenia is strong,
its etiology, pathophysiological mechanisms, and signifi-
cance for clinical symptoms are unclear. First, dysconnec-
tivity could result from aberrant wiring of connections
during development, from aberrant synaptic plasticity, or
from both. Second, it is not clear how schizophrenic symp-
toms can be understood mechanistically as a consequence
of dysconnectivity. Third, if dysconnectivity is the primary
pathophysiology, and not just an epiphenomenon, then it
should provide a mechanistic explanation for known empir-
ical facts about schizophrenia. This article addresses these
3 issues in the framework of the dysconnection hypothesis.
This theory postulates that the core pathology in schizo-
phrenia resides in aberrant N-methyl-D-aspartate receptor
(NMDAR)–mediated synaptic plasticity due to abnormal
regulation of NMDARs by neuromodulatory transmitters
like dopamine, serotonin, or acetylcholine. We argue that
this neurobiological mechanism can explain failures of self-
monitoring, leading to a mechanistic explanation for first-
rank symptoms as pathognomonic features of schizophrenia,
and may provide a basis for future diagnostic classifications
with physiologically defined patient subgroups. Finally, we
test the explanatory power of our theory against a list of
empirical facts about schizophrenia.
Key words: dysconnectivity/corollary discharge/
psychosis/hallucinations/delusions/NMDA/dopamine/
acetylcholine/serotonin/effective connectivity/dynamic
causal modeling/DCM/predictive coding
Introduction
Schizophrenia has largely remained an enigma. Despite
all research efforts, there is still no consensus about its
exact pathophysiological mechanisms. Over the last 2 cen-
turies, a large number of competing hypotheses have been
put forward, ranging from theories originating in genetics
and molecular biology to those formulated in terms of so-
cial psychology. This special issue of Schizophrenia Bulle-
tin challenges several scientists with somewhat different
views on schizophrenia. The task is to defend one’s favor-
ite theory and state to what degree it can explain a set of
‘‘established facts’’ about schizophrenia. These were se-
lected by the editors as facts that any decent theory should
explain. One can argue whether all the statements pro-
vided are really established facts or not. However, fact 1
is paradigmatic: schizophrenia has ‘‘a heterogeneous
presentation, with disorganized, positive, and negative
symptoms’’ (fact 1, see below). Within the positive symp-
toms, it is sometimes characterized by rather specific and
extraordinarily bizarre symptoms,1 in particular the first-
rank symptoms of Schneider2 (eg, delusions of control).
Although many patients currently classified as being
schizophrenic do not show first-rank symptoms, these
symptoms provide the toughest test for any account of
schizophrenia because they are completely outside our
normal experience. Any comprehensive theory of schizo-
phrenia should therefore be able to explain why these
particular symptoms frequently occur. In this article,
we defend the theory that schizophrenia results from dys-
connection and describe in detail how the dysconnection
hypothesis can explain first-rank (and other) symptoms
observed in schizophrenia and account for the remaining
facts compiled by the editors.
The notion that schizophrenia is not caused by focal
brain abnormalities, but results from pathological inter-
actions between brain regions, is an old and influential
idea in schizophrenia research. Wernicke3 was the first
to propose this hypothesis. He postulated that psychosis
arises from anatomical disruption of association fiber
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tracts and referred to this disruption as ‘‘sejunction.’’
Subsequently, a similar notion, but formulated in terms
of psychopathology, was expressed by Bleuler4 who
coined the term ‘‘schizophrenia’’ to denote the ‘‘splitting’’
of different mental domains. With the advent of nonin-
vasive neuroimaging techniques in the 1980s (positron
emission tomography, PET) and 1990s (functional mag-
netic resonance imaging, fMRI), this theme re-emerged in
experiments that showed abnormally distributed activity
and functional connectivity in schizophrenia.5–7 For ex-
ample, a PET study by Volkow et al8 found that ‘‘schizo-
phrenic subjects showed derangements in the pattern of
interactions among brain areas.’’ Similar conclusions em-
erged from cognitive activation studies, based on PET,
whose findings were ‘‘consistent with the notion that
schizophrenia involves pathology of and dysfunction
within a widely distributed neocortical-limbic neural net-
work.’’9 Similarly, analyses of cross-sectional studies sug-
gested ‘‘disinhibition of left medial temporal lobe activity
mediated by fronto-limbic connections.’’10 Following
these initial studies, further evidence for dysconnectivity
comes from at least 3 independent lines of research. First,
many studies have found abnormal functional connectiv-
ity between temporal and frontal regions as measured by
PET and fMRI.11–13 Second, magnetoencephalography/
electroencephalogram (MEG/EEG) studies have indi-
cated abnormal beta and gamma band synchrony during
sensory processing and cognitive tasks.14–18 Third, EEG
studies have found abnormal functional connectivity pat-
terns both during rest and during performance of various
tasks.19–22 In an attempt to provide a unifying neurobio-
logical explanation for these empirical observations, the
‘‘disconnection hypothesis’’ suggested that the core pathol-
ogy of schizophrenia is an impaired neuromodulation of
synaptic plasticity, leading to abnormal functional integra-
tion of neural systems, ie, dysconnectivity.6,23,24 Recently,
this hypothesis was updated in the light of new experimen-
tal findings, particularly from genetic studies.25
This article is structured as follows. After defining
what we mean by dysconnectivity, we suggest a specific
pathophysiological mechanism that underlies its occur-
rence in schizophrenia. Briefly, we postulate that the central
pathomechanism in schizophrenia is aberrant N-methyl-
D-aspartate receptor (NMDAR)–mediated synaptic
plasticity due to abnormal regulation of NMDARs by
neuromodulatory transmitters like dopamine (DA), ace-
tylcholine (ACh), or serotonin (5-HT). We then discuss
how dysconnectivity resulting from abnormal NMDAR-
dependent synaptic plasticity could lead to a fundamental
failure of self-monitoring (or corollary discharge) and
how the latter could explain the positive symptoms of
schizophrenia. Subsequently, we address how dysconnec-
tivity speaks to the empirical facts compiled by the edi-
tors. We conclude with a summary of a scientific strategy,
combining experimental and computational approaches,
by which critical predictions of the dysconnection hy-
pothesis can be tested and underline the importance of
having a theory.
What Do We Mean by ‘‘Dysconnectivity’’?
The 2 most frequently used terms in the schizophrenia
literature to describe abnormal brain connectivity are dis-
connectivity (or disconnection) and dysconnectivity (or
dysconnection). These terms are frequently used as if
they were identical in meaning and interchangeable. Et-
ymologically, however, they are quite different. Whereas
the Latin prefix ‘‘dis’’ means ‘‘apart,’’ the Greek prefix
‘‘dys’’ means ‘‘bad’’ or ‘‘ill.’’ Thus, ‘‘disconnection’’ refers
to the disintegration of cognitive functions in schizophre-
nia. This term might suggest that connectivity in schizo-
phrenia is necessarily reduced, leading to less interaction
between neural units. This is not what the original discon-
nection hypothesis meant to imply; instead, while some
functional interactions appear to be reduced (eg, func-
tional coupling between temporal and prefrontal regions
in language tasks),6 other functional interactions may be
abnormally increased.24 To avoid this confusion, we use
‘‘dysconnectivity.’’25 This term emphasizes the notion
that there is abnormal (rather than decreased) functional
integration among brain regions in schizophrenia.
Inconcreteneurobiologicalterms,wesuggestthatdyscon-
nectivity results from abnormal regulation of NMDAR-de-
pendent synaptic plasticity by modulatory transmitters like
DA, ACh, or 5-HT. NMDAR activation can change the
strength of glutamatergic synapses by altering the functional
state and/or number of a-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate receptors (AMPARs); this is achieved
by NMDAR-initiated phosphorylation of AMPAR subu-
nits or by trafficking of AMPARs into/out of the postsynap-
ticdensity.26–28 Importantly,NMDAR-dependentplasticity
can be controlled by modulatory transmitters through var-
ious mechanisms.29 For example, DA and ACh receptors
regulate the trafficking and insertion of NMDARs in the
cell membrane as well as their endocytosis, and these mech-
anisms are known to be highly relevant for pathophysiolog-
ical processes in several brain diseases.30 Furthermore, the
conductance properties of NMDARs depend on their phos-
phorylation status, and this is under strong control by DA
and5-HTreceptors.31–34 Finally,AChand5-HTalso impact
on the relative expression of different NMDAR subunits,
leading to NMDARs of different molecular structure and
electrophysiological properties.35–39 It is this regulatory ef-
fect of modulatory transmitters on NMDAR-dependent
synaptic plasticity that is central to the dysconnection hy-
pothesisandthatdistinguishes it fromotherpathophysiolog-
ical theories of schizophrenia that postulate impaired
NMDAR function alone.40–44
What Causes Dysconnection?
Two possible explanations for how dysconnection arises
are currently being discussed, a cellular and a synaptic
K. E. Stephan et al.
510
one. Interregional functional coupling might be abnor-
mal in schizophrenia because of impairments of struc-
tural (anatomical) connectivity, eg, due to aberrant
wiring of association fibers during brain development.45
This explanation rests on the abnormal deployment of
cellular processes like axons. Alternatively, functional
coupling could be disturbed due to impairments in syn-
aptic plasticity.24 (Of course, dysconnectivity resulting
from abnormal synaptic plasticity must also have struc-
tural correlates, eg, changes in the morphology or distri-
bution of dendritic spines, the numbers of transmitter
receptors, their composition out of different subunits,
or their phosphorylation status. Here, we restrict the
term ‘‘impaired structural connectivity’’ to the level of
cellular processes such as axonal fiber bundles.) Impor-
tantly, however, aberrant wiring of connections and im-
paired synaptic plasticity are not necessarily exclusive but
could coexist because they have a common (genetic)
cause or because one causes the other.25 For example,
some candidate genes for schizophrenia play a role in
establishing long-range connections during development
as well as in the regulation of synaptic plasticity (eg, neu-
regulin 1, NRG146). Furthermore, any impairment in
synaptic plasticity would affect the survival of long-range
connections in the developing brain and thus the resulting
pattern of anatomical connectivity in later life. This is be-
cause the strength of functional coupling between neu-
rons, which depends on experience-dependent synaptic
plasticity mediated by NMDARs,47 determines whether
their connection survives developmental pruning.48 Dys-
connectivity due to impaired modulation of NMDAR-
dependent synaptic plasticity is consistent with the
fact that schizophrenia cannot be explained by genetics
alone but only by interactions between genes and
environment.49
In a recent article,25 we assessed the relative evidence
for these 2 mechanisms and concluded that while there
is so far inconclusive data on alterations of anatomical
connectivity, the notion of abnormal modulation of
NMDAR-dependent synaptic plasticity in schizophrenia
is supported by converging evidence from multiple lines
of research. In the following, we review this evidence
briefly.
Neurophysiology
One of the most robust findings in schizophrenia research
is that patients show a significant reduction of the ‘‘mis-
match negativity’’ (MMN) event-related potential.50
According to a recent meta-analysis,51 this finding has
been replicated by more than 30 studies. There is strong
evidence that the MMN represents a prediction error sig-
nal during implicit perceptual learning and depends crit-
ically on synaptic plasticity.25,52,53 For example, the
NMDA antagonist ketamine reduces the MMN in
healthy volunteers, rendering it very similar to that of
patients.54,55 Furthermore, invasive recording studies in
monkeys with local infusion of ketamine have demon-
strated the dependence of the MMN on NMDAR-
mediated synaptic plasticity;56 in humans, this plasticity
is modulated by ACh and 5-HT, both of which alter the
MMN.57,58 A recent electrophysiological study has also
provided evidence for impairment of synaptic plasticity
during procedural (motor) learning in schizophrenic
patients. Daskalakis et al59 used a well-established, phar-
macologically validated transcranial magnetic stimula-
tion paradigm60 to demonstrate impaired synaptic
plasticity in the motor cortex of schizophrenic patients:
both medicated and unmedicated patients demonstrated
significantly reduced posttreatment motor reorganiza-
tion compared with healthy subjects. Finally, there is in-
creasing evidence that delusions in schizophrenia are
a likely result of abnormal reinforcement learning,61–64
a process that depends on DAergic modulation of
NMDAR-mediated synaptic plasticity.65,66
Neuropharmacology
Various drugs that impact on synaptic plasticity (eg,
NMDA antagonists, DA agonists (D2), and 5-HT ago-
nists) can induce psychotic symptoms in healthy subjects,
following chronic use or high single doses.40,67–69 In par-
ticular, the psychotic symptoms and cognitive deficits in-
duced by NMDA antagonists overlap with those of
schizophrenia.70 Notably, NMDAR-dependent plastic-
ity can occur very quickly, ie, from seconds to
minutes.26–28 However, NMDAR activation also elicits
excitatory postsynaptic potentials (EPSPs).71,72 There-
fore, it is likely that the cognitive effects seen after ket-
amine administration to healthy volunteers result both
from reducing EPSPs and from diminishing NMDAR-
dependent synaptic plasticity.
Neuropathology
Reductions in dendritic field size and dendritic spines of
cortical neurons have been reported consistently in post-
mortem studies of schizophrenia.73–76 This microstructural
deficit might be a consequence of impaired synaptic plastic-
ity: one of the most important promoters of dendritic
growth and dendritic spine formation is activation of
NMDARs.77–79 In contrast, blocking NMDARs decreases
dendritic length and spine density.80–82
Genetics
A majority of the currently strongest candidate genes for
schizophrenia, as determined by linkage and association
studies, play an important role in NMDAR-dependent
signaling and plasticity and its regulation by DA and
ACh.25,83 Additionally, a recent genetic study that found
a strong increase in structural variants (ie, chromosomal
microduplications and microdeletions) in the genome of
schizophrenic subjects highlighted that many of these
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mutations affected genes involved in NMDAR-dependent
plasticity of glutamatergic synapses.84 The genetic findings
on schizophrenia and their relation to the dysconnection
hypothesis are reviewed in more detail below (fact 3).
Interactions Among Different Neurotransmitter Systems
There is a growing body of evidence that documented ab-
normalities of c-aminobutyric acid–mediated (GABAer-
gic) and DAergic function in schizophrenia may result
from NMDAR dysfunction.85,86 For example, glutama-
tergic projections from prefrontal cortex and various sub-
cortical regions regulate the activity of DAergic neurons
in the ventral tegmental area (VTA).87,88 Importantly, the
strength of these projections is controlled by NMDAR-
dependent synaptic plasticity89–91 and targets 2 different
neuronal populations in the VTA: (1) DAergic neurons
that project to the DLPFC (where their effects are mainly
mediated by D1 receptors) and (2) GABAergic neurons
that project to the nucleus accumbens and (probably)
also dampen DAergic mesostriatal projections.88,92,93
(So far, there is no anatomical but only indirect neuro-
physiological evidence that mesostriatal DA neurons in
VTA are inhibited locally by those GABAergic neurons
that receive direct input from prefrontal cortex.88,93) From
this, one can predict that hypofunction of NMDARs
decreases prefrontal input to VTA, resulting in reduced
activity of GABAergic interneurons in VTA and thus
in increased activity of DAergic cells projecting to the
striatum via D2 receptors; at the same time, reduced pre-
frontal input to VTA decreases activity of DAergic neu-
rons projecting back to the DLPFC via D1 receptors.86
Indeed, NMDAR blockade mimics the amphetamine-
induced abnormalities of DA release in the striatum
(presumably through disinhibition of the DAergic me-
sostriatal projections) that are seen in schizophrenic
patients.94–99 It is thus conceivable that, at least in
some patients, DAergic dysfunction is a consequence
of primary NMDAR dysfunction. However, it must
also be considered that the NMDAR-dependent plastic-
ity of prefrontal projections to VTA is modulated by DA
itself.100–102 It is thus likely that the prefrontal hypo-
DAergic and striatal hyper-DAergic effects resulting
from NMDAR blockade as described above can also
be achieved by aberrant modulation of NMDARs by
DA. Crucially, these lines of evidence point to the impor-
tance of interactions among NMDAR-dependent plastic-
ity and DAergic modulation,103 as opposed to an isolated
NMDAR dysfunction. Moreover, the NMDAR-
dependent plasticity of prefrontal projections to VTA
is also regulated by nicotinic receptors90 and 5-HT
receptors.89 Therefore, similar considerations as for
DA apply to the role of interactions between NMDARs
and ACh/5-HT for the pathophysiology of schizophrenia.25
The putative mechanisms behind this interaction, which are
central to the dysconnection hypothesis, are reviewed in
more detail below.
Collectively, the experimental evidence summarized
above indicates that schizophrenia is a spectrum disease
that may be caused by different genetic mechanisms and
pathophysiological processes; these processes, however,
appear to converge onto the same functional pathway,
ie, the regulation of NMDAR-controlled plasticity of
glutamatergic synapses by neuromodulatory transmitters
like DA, 5-HT, and ACh. In contrast to this converging
evidence for impaired regulation of plasticity of glutama-
tergic synapses as a cause of dysconnectivity in schizo-
phrenia, it is not clear yet whether altered patterns of
anatomical long-range connections coexist. Given the
evidence summarized above that impaired experience-
dependent plasticity due to NMDAR dysfunction impacts
on selection and pruning of axonal connections during
neurodevelopment,47,48 the dysconnection hypothesis
would predict that such structural alterations of connectiv-
ity exist. So far, the only available technique for in vivo
measurements of human brain connectivity, diffusion-
weighted imaging, has yielded inconsistent results.104–106
However, this may be due to an immature state of this
technique, and it is possible that technological refinements,
enhanced spatial resolution, and improved analysis tech-
niques might lead to more consistent results in the future.
Alternative approaches that allow for indirect assessments
of structural connectivity changes, eg, multivariate analy-
ses of covariations in regional brain volume or morpho-
metric analyses of white matter maps, have indicated
that disturbances of anatomical connectivity may exist
in schizophrenia.107–110 From a mechanistic perspective,
however, the issue is not so much whether one would ex-
pect to see disrupted axonal connectivity or not but
whether this alteration is secondary to or independent
from abnormal synaptic plasticity. This is an important
question for future research.
How Does Dysconnectivity Relate to the Clinical First-
Rank Symptoms of Schizophrenia?
It is currently fashionable to explain a wide range of clin-
ical disorders, such as dyslexia or autism, in terms of
dysconnectivity.111,112 Any serious pathophysiological
theory based on dysconnectivity should fulfill at least 2
criteria. First, it should provide a neurobiologically pre-
cise explanation of what causes the dysconnection. The
dysconnection hypothesis, for which the evidence is sum-
marized above, provides such an explanation: it suggests
that the underlying cause of dysconnectivity in schizo-
phrenia is a specific impairment of synaptic plasticity,
which results from aberrant modulation of NMDAR
function by DA, ACh, and 5-HT. This abnormal modu-
lation can be described in neurobiologically precise
terms; eg, DA, ACh, and 5-HT receptor activation ini-
tiates intracellular cascades that lead to alterations in
the conductance properties of NMDARs due to changes
in phosphorylation status or receptor subunit expression
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and to alterations of NMDAR receptor trafficking (for
details, see above and Stephan et al25). Second, any dys-
connection theory should provide a mechanistic explana-
tion for the cognitive symptoms that are specific to the
particular disease. In this section, we provide such an
explanation for schizophrenia. We will focus on how
first-rank symptoms,2 such as delusions of control,
may be explained as the failure of self-monitoring mech-
anisms,113–116 also referred to as ‘‘corollary discharge’’
mechanisms. In the following section, we link all levels—
synaptic plasticity, corollary discharge, and clinical
symptoms—by summarizing recent evidence that corol-
lary discharge mechanisms depend on synaptic plasticity.
First-rank symptoms, which were initially defined by
Schneider in an attempt to isolate those symptoms that
are pathognomonic of schizophrenia,2 continue to have
major importance in clinical classifications of schizophre-
nia. First-rank symptoms are essentially experiences of
‘‘passivity,’’ ie, patients report that their actions, thoughts,
or emotions are no longer caused by themselves but are
imposed upon them by external forces or agents. For ex-
ample, schizophrenic patients may report that their
thoughts are being ‘‘inserted’’ or ‘‘broadcast,’’ that alien
voices may tell them what to do or comment on their
actions, or that some external force or agent is controlling
their movements. While many patients who fulfill current
diagnostic criteria for schizophrenia do not have first-
rank symptoms, these are the symptoms that are the
most difficult to understand because they are so far out-
side our normal experience. These symptoms, therefore,
provide the toughest test for any account of schizophrenia.
First-rank symptoms may result from a diminished abil-
ity to distinguish between events that we control (eg, self-
generated inner speech or limb movements) and those that
occur independently of us in the external world (eg, some-
one else speaking or some external force moving our
limbs). Normally, we can differentiate between these
events depending on how well we can predict the sensory
input they evoke. For example, regardless of whether we
actively move our arm or whether our arm is moved by
someone else, somatosensory areas of our brain receive in-
put from peripheral proprioceptors. However, when the
movement is self-generated, the sensory areas also receive
a signal from motor areas, informing them about the
intended movement and thus allowing them to predict
the proprioceptive input they should be receiving. This sig-
nal has been called a ‘‘corollary discharge,’’117 or ‘‘effer-
ence copy.’’118 The prediction conveyed by corollary
discharge from motor areas may be used to cancel or ex-
plain away the sensation that is normally associated with
proprioceptive input and the associated activation of sen-
sory areas. A corresponding corollary discharge mecha-
nism is used to deal with changes in visual perception
induced by self-generated eye movements. Neurophysio-
logical studies in primates suggest that during self-
generated saccades the frontal eye field receives a corollary
discharge signal from the superior colliculus that may be
used for coordinating sequential saccades and for stabiliz-
ing vision across saccades.119,120 Similarly, there is evi-
dence from human fMRI studies that during eye blinks
frontal oculomotor regions send a corollary discharge sig-
nal to visual areas, probably to ensure a stable visual per-
cept across blinks.121
In essence, the notion that the first-rank symptoms of
schizophrenia result from a failure of self-monitoring, or
corollary discharge refers to a dysconnection between
a motor act (which may or may not be conscious) and
its sensory consequences. Several studies have provided
evidence for this type of dysconnection in schizophrenia
and demonstrated that self-monitoring is indeed ab-
normal in patients. In a series of EEG studies, Ford,
Mathalon, and colleagues have demonstrated a reduction
in functional connectivity between areas that initiate an
action and areas that mediate the perception of the sen-
sory consequences of that action.122–124 For example,
they examined the hypothesis that both before and dur-
ing talking a corollary discharge mechanism, expressed
through functional frontotemporal connectivity, may
act to prepare temporal auditory areas for the sounds
generated by frontal areas. They argue that a disruption
of this functional connectivity would lead to mismatch
between the expected auditory consequences of self-
generated speech and the actual auditory experi-
ence.122,123 Ford et al122 found that whereas frontotem-
poral delta and theta band coherence was enhanced
during talking (compared with listening) in healthy vol-
unteers, schizophrenic patients failed to show this corre-
late of corollary discharge; this failure was particularly
pronounced in patients with auditory hallucinations.
These results suggest that in schizophrenia an impair-
ment of corollary discharge may prevent frontal areas
generating thoughts (inner speech) from informing audi-
tory areas that this inner speech is self-generated. This
could lead to a misattribution of inner speech to external
sources and thus produce auditory hallucinations.125
These conclusions were supported by an independent
fMRI study of a sentence completion task (the Hayling
Test) in schizophrenic patients.12 Compared with healthy
controls, patients showed reduced functional connectiv-
ity between prefrontal and temporal regions; further-
more, the degree of dysconnection was inversely
correlated with the severity of their hallucinations.
There are many further studies that have provided ev-
idence for dysconnection between prefrontal and tempo-
ral regions11,19,126,127 (note, however, that for some
language tasks, temporal regions exhibited dysconnectiv-
ity not with prefrontal but with other brain regions128).
Space constraints prevent us from discussing all these
studies in detail. Finally, it should be noted that evidence
for impaired corollary discharge mechanisms is not re-
stricted to speech generation. Other studies have obtain-
ed equivalent evidence concerning the somatosensory
513
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perception of the consequences of limb movements,129,130
of self-generated sensory stimuli,131 the visual consequen-
ces of limb movements,132 and the visual consequences of
eye movements.133
Our hypothesis does not provide a precise explanation
of the exact content of hallucinations and delusions. One
likely possibility is that this content is determined by
prior individual differences in brain physiology, experi-
ence, culture, etc, which are not in themselves part of
the psychotic process. Empirical evidence for this notion
was obtained recently by an fMRI study of healthy vol-
unteers showing that the individual predisposition to de-
veloping psychotic symptoms under ketamine was
predicted by regional brain responses during cognitive
tasks under placebo.134
Can Dysconnection Also Explain Negative and Cognitive
Symptoms of Schizophrenia?
The focus of this article is on explaining how positive
symptoms in schizophrenia result from impaired percep-
tual inference, caused by aberrant corollary discharge,
which, as explained, results from abnormal regulation
of NMDA-dependent synaptic plasticity by modulatory
transmitters like DA, ACh, and 5HT. Nevertheless, we
would like to comment briefly on how other symptoms
of schizophrenia, ie, negative and cognitive symptoms,
could also be explained by abnormal modulation of syn-
aptic plasticity and understood as instances of dysfunc-
tional perceptual learning. Negative symptoms, eg,
blunted affect and social withdrawal, can be understood
as resulting from a failure of operant and emotional learn-
ing during social interactions. In other words, if abnormal
synaptic plasticity renders the patient incapable of learning
from social experiences and thus from adaptive changes in
the cognitive and motor processes required for successful
social exchange, he/she will experience the world as frus-
trating and unpredictable, which is likely to trigger social
withdrawal and apathy. Concerning the various cognitive
symptoms frequently seen in schizophrenia, many, if not
all, of them can also be understood as a consequence of
aberrant modulation of synaptic plasticity, eg, deficits in
(various types of) learning and memory, which are prom-
inent cognitive symptoms in schizophrenia.135 These gen-
eral impairments in learning are likely to have profound
downstream effects on other cognitive processes: eg, im-
paired regulation of synaptic plasticity by DA is known
to disturb associative learning processes,63,64,136 and the
resulting ‘‘loosening’’ of associations may cause thought
disorder, altered speech, and deficits in reasoning.
How Does Synaptic Plasticity Relate to Corollary
Discharge Mechanisms?
The problem of distinguishing between self-generated
and externally generated actions, which was initially
described by von Helmholtz,137 is an evolutionary very
old one and faces any creature that is able to perform
limb or eye movements. It is therefore not surprising
that corollary discharge mechanisms have been described
in a large range of organisms, including insects,138,139
fish,140–142 bats,143 birds,144 rodents,145 cats,146 and pri-
mates.119,120 Self-monitoring relies on forming a predic-
tion about the expected sensory consequences of one’s
action, triggered by a corollary discharge, and then sub-
tracting this prediction from the actual sensory input. Im-
portantly, the sensory input associated with a given
action can change due to contextual or environmental
factors. As an example, the dynamics of proprioceptive
input following a particular arm movement differ de-
pending whether this movement is performed in air or
in water during swimming. Also, predictions about pro-
prioceptive input have to be updated rapidly and contin-
uously when performing movements in the presence of
additional external forces (eg, strong wind or water cur-
rents) or when being exposed to novel mappings between
motor actions and sensory outcome. This means that
at the neuronal level, self-monitoring must be imple-
mented by a system that is capable of rapid adaptation
and plasticity.
Indeed, elegant neurophysiological studies in fish have
demonstrated that there are at least 2 separate subsys-
tems for corollary discharge: one system that deals
with situations where the relation between motor action
and sensory input is invariant and one where this relation
changes due to contextual or environmental factors.140 In
the former case, the canceling out of sensory inputs is
implemented through temporally highly precise inhibi-
tory postsynaptic potentials that are triggered by corol-
lary discharge138,140; for this mechanism, no synaptic
plasticity is needed. In the latter case, however, corollary
discharge mechanisms depend critically on spike-timing–
dependent plasticity (STDP), a form of short-term synap-
tic plasticity that critically relies on NMDARs147–151 and
is regulated by DA, ACh, and 5-HT.152–154 In brief, Bell
and colleagues140–142 showed that cerebellum-like struc-
tures in electric fish act as adaptive sensory processors, in
which learned predictions about sensory input are sub-
tracted from actual sensory input; notably, there is recent
evidence that the cerebellum has a similar role in
humans.155 In their experiments, responses of Purkinje-
like medium ganglion (MG) cells to central corollary dis-
charge signals were ‘‘negative images’’ of responses to
previously paired sensory inputs; adding these to concur-
rent sensory input suppressed MG cells responses.141
Neuroanatomically, sensory inputs are relayed to basal
dendrites of MG cells, whereas predictive corollary dis-
charge signals are transmitted by parallel fibers to the
apical dendrites of MG cells. Bell and colleagues141,142,156
showed in several studies that the mechanism generating
negative images of predicted inputs relied on NMDAR-
mediated plasticity of parallel fiber synapses. This
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plasticity was of an anti-Hebbian nature (ie, EPSPs were
depressed after pairing with a postsynaptic spike) and
strongly spike-timing dependent, with depression occur-
ring only if the postsynaptic spike followed EPSP onset
within a narrow time window of 60 milliseconds. A next
step will be to demonstrate directly that corollary dis-
charge depends on neuromodulatory regulation of
NMDAR-dependent plasticity; this dependence is very
likely given that STDP relies on this mechanism (see
above). While functional data are lacking so far, neuro-
anatomical studies indeed indicate a role of modulation
by DA and 5-HT in corollary discharge.157,158
Altogether, the experimental results discussed in this
and the previous sections provide a framework for under-
standing some of the symptoms in schizophrenia, namely,
first-rank symptoms including delusions of control and
hallucinations. This framework explains how first-rank
symptoms can be understood as an impairment of corol-
lary discharge and thus as a dysconnection between a mo-
tor act and its sensory consequences and how such
failures of corollary discharge can be linked to neurobi-
ological mechanisms (ie, synaptic plasticity) that are
known to be disturbed in schizophrenia.
It is interesting to note that corollary discharge is im-
plicit in ‘‘predictive coding.’’ Predictive coding is a general
framework that, put simply, requires the brain to mini-
mize prediction error. It suggests that hierarchically
arranged neural systems optimize their functional inter-
actions, through message passing (inference) and short-
and long-term synaptic plasticity, such that the difference
between the sensory inputs, conveyed by bottom-up
inputs and a prediction about this input, mediated by
top-down projections, is minimized or ‘‘explained
away.’’53,159 This framework includes corollary discharge
as a special case, where predictions are generated by mo-
tor structures and prediction error is minimized in
sensory areas (cf Figure 3 in Kilner et al160). This perspec-
tive might be useful for explaining symptoms of schizo-
phrenia beyond delusions of control. For example,
Friston53 outlined how hallucinations (in any modality)
could be explained as a failure of predictive coding, where
the precision (encoded in the postsynaptic sensitivity of
units encoding prediction error) of prior expectations
is abnormally high. This produces a suboptimal balance
between sensory inputs and prior expectations leading to
distorted predictions of what caused a particular sensa-
tion. In other words, if too much weight is afforded to
prior expectations, false inferences about the cause of
a perceptual state may ensue. This will lead to a failure
of explaining away prediction error and increased activity
in subordinate levels of processing hierarchies; this is ex-
actly what has been seen by fMRI measurements of au-
ditory hallucinations in patients.161–163 Similarly,
delusions, including the delusions of persecution (that
are among the most frequent symptom associated with
schizophrenia), can be explained as failure of hierarchical
inference, leading to an imbalance between new evidence
and prior beliefs.
We recognize that hallucinations and delusions can be
observed in diagnostic categories other than schizophre-
nia. Even first-rank symptoms are sometimes observed in
bipolar patients, and other forms of hallucination and de-
lusion are associated with disorders such as Charles
Bonnet syndrome, Capgras syndrome, and anosognosia.
We suggest that all these phenomena reflect an imbalance
between evidence (sensory inputs) and prior beliefs
(expectations). However, this imbalance may have differ-
ent causes at the physiological level. For example, in
Charles Bonnet syndrome, the cause is the random visual
input consequent upon retinal degeneration. As a result,
visual hallucinations are created by unconstrained oper-
ation of learned expectations about visual inputs.
In theoretical treatments of learning and prediction,
like predictive coding, uncertainty or the amplitude of
prediction error is often thought of as being encoded
by DA and other neuromodulators,164–166 which play
a central role in optimizing synaptic connection
strengths.29–39,152–154 This is one important reason why
the dysconnection hypothesis focuses on the role of neu-
romodulators in synaptic plasticity.
Can the Dysconnection Hypothesis Explain Established
Facts About Schizophrenia?
In the following, we consider the list of established facts
about schizophrenia (in italics) that were selected by the
editors and examine whether and how precisely they can
be explained by the dysconnection hypothesis.
1. Schizophrenia has a heterogeneous presentation, with
disorganized, positive, and negative symptoms having
different levels of prominence across time and across
individuals.
The clinical heterogeneity of schizophrenia has long
given rise to the notion that it is not a single disease
but a spectrum of diseases.167 This could be explained in-
dependently by 2 principles: (1) different pathophysiolog-
ical processes may underlie schizophrenia but converge
onto the same, or similar, functional pathways and (2)
a particular pathophysiological process may be strongly
modulated by factors that differ across patients and
change over time within a given patient. The dysconnec-
tion hypothesis, as outlined above, accommodates both
principles.
Concerning the first principle, we postulate that
NMDAR-dependent synaptic plasticity is impaired due
to an abnormality of the regulation of NMDARs by neu-
romodulatory transmitters like DA, ACh, and 5-HT
(which control, eg, phosphorylation, subunit composi-
tion, and trafficking of NMDARs).30–39 This means
that a patient in whom the dominant abnormality is
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a DAergic dysregulation of NMDARs is likely to show
different symptoms (eg, a predominance of delusions
resulting from impaired reinforcement learning)61–64
than a patient in whom the primary abnormality is a cho-
linergic dysregulation of NMDARs (where symptoms
might be dominated by perceptual abnormalities like hal-
lucinations and impaired attention).24,168 In other words,
from the perspective of the dysconnection hypothesis, the
diversity of clinical symptoms is due to differences in
where dysfunctional experience-dependent plasticity is
expressed in the brain. These (between-subject) differen-
ces may be at the level of the molecular biology mediating
the effect of different modulator neurotransmitters on
NMDAR plasticity or (within-subject) differences in
the sensory experience or environmental influence (see
below) inducing plasticity.
With regard to the second principle, NMDA-dependent
synaptic plasticity is a process that is strongly modulated
by hormonal,169–171 immunological,172–175 and metabolic
factors.176 Similarly, DAergic, cholinergic, and 5-
HTergic transmission (and thus their regulation of
NMDA-dependent synaptic plasticity) are subject to
developmental changes throughout life and modulation
by nonneuronal factors.177,178 Together, these changes
in synaptic plasticity over the life span of an individual
patient may contribute to fluctuations of clinical
symptoms over time.
2. Schizophrenia has a peak of onset in young adulthood
and is rare before adolescence or after middle age.
Onset also interacts with sex, such that men are likely
to become ill earlier in life than women. Prevalence is
greater in men throughout most of adulthood but is
equal by the end of the risk period.
The peak of onset of schizophrenia and the strong sex
differences suggest a hormonal influence that changes
markedly during neurodevelopment, eg, steroidal
hormones like cortisol, estrogens, or androgens. Sensitiv-
ity to developmental factors and gender are inevitable un-
der the dysconnection hypothesis because NMDAR-
dependent synaptic plasticity is profoundly altered by
both cortisol169 and estrogens.170,171 As noted earlier,24
‘‘the fact that schizophrenia is expressed symptomatically
in adulthood points to an abnormal modulation of
experience-dependent plasticity, as distinct from the in-
duction and maintenance of synaptic connections through
epigenetic mechanisms or indeed activity-dependent plas-
ticity in utero: for example, there is no evidence to suggest
that the ocular dominance columns in the striate cortex of
schizophrenics are abnormal.’’
The sex difference in onset is simply explained by hor-
monal mechanisms that exert a protective effect on syn-
aptic plasticity in females but less so in males. Such
a mechanism exists: it has been shown that estrogens
markedly enhance NMDAR-dependent plasticity of glu-
tamatergic synapses, leading to increased postsynaptic
efficacy of NMDARs, enhanced long-term potentiation
(LTP), and also behavioral improvements, eg, in memory
tasks.170,171,179 Estrogens also prevent stress-induced loss
of LTP in the hippocampus.180 In contrast, the effects
of androgens on synaptic plasticity in general, and
NMDAR-dependent plasticity in particular, are much
less well documented. While some studies reported ben-
eficial effects of androgens, ie, maintaining dendritic
spines of hippocampal CA1 pyramidal neurons,181 other
studies demonstrated detrimental effects of androgens on
NMDAR-dependent synaptic plasticity, namely, a de-
crease in LTP182 and a reduction of the expression of
specific NMDAR subunits.183 Furthermore, animal stud-
ies have demonstrated that androgen-mediated regulation
of spine density is found in both sexes, whereas plasticity-
enhancing effects of estrogens are observed in females
only.181 These neurophysiological findings are comple-
mented by endocrine measurements in drug-free first-
episode patients, which found decreased estrogen levels
in females.184 Altogether, the currently available experi-
mental data imply that estrogens may exert a protective
effect on NMDAR-dependent synaptic plasticity that
may delay the onset of schizophrenia in genetically pre-
disposed females. In contrast, such a protective effect
does not appear to exist in males, which explains the ear-
lier onset of schizophrenia in men.
3. Liability to schizophrenia is highly heritable (about
0.81), and concordance between identical twins is al-
most 50%, suggesting a role for environmental or sto-
chastic influences as well.
The interaction between genetic and environmental fac-
tors is an inevitable and necessary consequence of the dys-
connection hypothesis. This is because the molecular
mechanisms underlying the control of synaptic plasticity
are specified genetically and epigenetically, whereas the
functional expression of synaptic plasticity rests explicitly
on the exchange with the environment and the resulting
sensory experience and changes in internal milieu.
It has long been known that schizophrenia is a polyge-
netic disease that is strongly modulated by environmental
factors.167 Over the last few years, a large number of ge-
netic linkage and association studies have been con-
ducted which, despite considerable inconsistency across
studies, have led to 3 major provisional conclusions.
First, it is likely that schizophrenia is caused by a combi-
nation of common alleles, each of which contributes
a small increase in the risk for illness.185 Second, given
the clinical heterogeneity of schizophrenia, it has long
been suspected that what we call schizophrenia is not
a single disease but a spectrum of diseases caused by dif-
ferent pathophysiological processes.167 This notion is
compatible with the variability across genetic linkage
studies186 and the variability in patient-specific profiles
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of gene expression.187 The final and perhaps most impor-
tant conclusion is that, although patients may differ in
their genetic risk profile, the resulting pathophysiological
processes ultimately leading to schizophrenia may never-
theless converge onto the same functional pathway. In-
deed, a unifying theme of the available genetic studies
is that many, if not most, candidate genes for schizophre-
nia are intimately related to some aspect of glutamatergic
synaptic signaling,25 notably NMDAR-dependent plas-
ticity and/or to neuromodulatory transmitters like DA,
5-HT, and ACh that exert strong control over NMDAR
function. In a recent review on the genetics of schizophre-
nia, Harrison and Weinberger83 identified 7 candidate
genes for schizophrenia for which at least 3 studies pro-
vided positive evidence; 6 of these genes are related, di-
rectly or indirectly, to NMDAR function. They
concluded that these candidate genes ‘‘. predispose,
in various ways but in a convergent fashion, to the central
pathophysiological process: an alteration in synaptic
plasticity, especially affecting NMDAR-mediated gluta-
matergic transmission..’’ It is remarkable that a recent
study that was based on a completely different working
hypothesis about the genetics of schizophrenia came to
the same conclusion. Walsh et al84 postulated that schizo-
phrenia may not only be caused by a combination of
risk-enhancing alleles but may also, and possibly more
frequently, be caused by microduplications and microde-
letions, ie, individually specific chromosomal mutations,
also known as structural variants. In their genome-wide
scans, they found structural variants in only 5% of con-
trol subjects, but in 15% of adult schizophrenic patients
and 20% of young-onset patients, both highly significant
differences. Most importantly, these mutations affected,
to a large degree, genes that are involved in signaling and
plasticity of glutamatergic synapses, eg, erbB4 and NRG1
signaling (NRG1 is a potent regulator of NMDAR func-
tion, reducing its synaptic currents and increasing its en-
docytosis188). Furthermore, a study of high-risk subjects
reported that the risk allele in the NRG1 promotor region
was associated with the development of psychotic symp-
toms.189 These genetic findings are complemented by
results from recent gene expression studies using a new
postmortem tissue stimulation approach, which found
that in schizophrenic patients NRG1-induced suppres-
sion of NMDAR function was considerably higher
than in controls subjects.190
It is important to note that under the dysconnection
hypothesis the phenotypic expression of abnormal
experience-dependent plasticity is limited to those plastic
mechanisms that are sensitive to neuromodulatory regu-
lation. This is particularly relevant for DA that has been
clearly implicated in value and emotional learning,164,165
that is central for predicting not only one’s own behavior
(eg, through corollary discharges) but also the behavior
of others (eg, theory of mind). Furthermore, NMDAR-
dependent synaptic plasticity can be modulated by envi-
ronmental factors, often via the internal milieu of the
body. For example, increased cortisol levels, eg, induced
by psychosocial stress, inhibit NMDAR currents and
LTP.169 Similarly, some proinflammatory cytokines, eg,
interleukin-1 and interleukin-18, attenuate NMDAR-
dependent LTP,172,173,175 while other cytokines activate
enzymatic pathways that lead to an accumulation of
kynurenic acid, an endogenous NMDAR antagonist.174
These examples demonstrate how a genetically encoded
basic mechanism of brain function, ie, NMDA-dependent
plasticity and its regulation by modulatory transmitters,
can be altered by humoral factors whose expression de-
pend on environmental influences.
4. All drugs with established antipsychotic effects block
DA D2-like receptors, but antipsychotic drugs are
not effective for all schizophrenia symptoms. Among
available agents, the atypical antipsychotic Clozaril
is the most effective; however, it carries unique risks
for some.
This is a complex point with several aspects, which we
address one by one. First, the fact that all antipsychotic
drugs block DA D2 receptors is a cornerstone of the dys-
connection hypothesis. There is much experimental evi-
dence on bidirectional interactions between NMDAR
and DA receptor signaling that explains the beneficial
effects of D2 blockade in schizophrenia. On the one
hand, glutamatergic afferents from prefrontal cortex pro-
ject to VTA, regulating the activity of DAergic midbrain
neurons and their projections to the striatum.87,88,92 Crit-
ically, the strength of these prefrontal projections to VTA
is regulated through NMDAR-dependent plasticity,89–91
which, in turn, is modulated by DA.100–102 This provides
a mechanism for the DA system to regulate its own inputs
and endow these inputs with acquired value.164 A failure
of DA-modulated NMDAR plasticity would lead to dys-
functional DA release from midbrain projections in the
striatum and severely impaired value learning. Indeed,
both human PET and rodent microdialysis studies
have demonstrated that acute NMDA blockade by ket-
amine led to a massive enhancement of amphetamine-
induced DA release in the striatum,96,99 similar to
what is seen in schizophrenic patients.94,95,97,98 Generally,
DA exerts strong control over NMDAR-mediated plas-
ticity. Briefly, D1 receptor activation increases NMDAR
transmission and LTP, whereas D2 receptor activation
decreases it.85,191 This depressive effect of D2 receptors
on LTP is reversed by antipsychotic medication.192
Heuristically, NMDAR hypofunction and excessive D2
receptor activation mutually reinforce each other; en-
hancing the former and inhibiting the latter may break
this pathological impasse.85
Second, the fact that antipsychotic drugs are not effec-
tive for all schizophrenia symptoms, or indeed for all
patients, fits well with the notion that different subgroups
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of patients show distinct neuromodulator-specific im-
pairments in NMDAR-dependent plasticity. From this
perspective, no single drug will work equally effectively
for all patients (see also point 6 below). One critical future
challenge is to devise methods for delineating patient sub-
groups that are physiologically defined through one or
several specific impairments in NMDAR-dependent
plasticity;25 see ‘‘From Dysconnectivity to Model-Based
Diagnostics’’ of this article for more details.
Third, the fact that atypical antipsychotic Clozaril (clo-
zapine) is the most effective of currently available drugs
may be due to its unique efficacy in promoting synaptic
plasticity. For example, there is some evidence that clo-
zapine might not only antagonize D2 receptors but at the
same time might also act as a partial agonist at D1 recep-
tors, thus promoting NMDAR-dependent synaptic plas-
ticity in 2 independent ways.193,194 Furthermore, in vitro
studies of rat hippocampal neurons demonstrated that
haloperidol decreased dendritic spine numbers and the
expression of proteins in the postsynaptic density of
NMDARs, whereas these critical components of gluta-
matergic plasticity were strongly enhanced (up to 70%)
by clozapine.195
5. Several early neurological insults, later life stressors
and nonhereditary genetic risk factors confer additional
risk. These include (in order of impact) migrant status,
older fathers, Toxoplasmosis gondii antibodies, prena-
tal famine, lifetime cannabis use, obstetrical com-
plications, urban rearing, and winter or spring birth.
This wide range of risk factor can only be explained in
terms of a fundamental aspect of brain function, which is
affected by experience-dependent, humoral, and develop-
mental factors. NMDAR-dependent synaptic plasticity
and its regulation by neuromodulatory systems represent
such a fundamental mechanism that is affected by immu-
nological, metabolic, and hormonal factors.169,174,176 For
example, both migrant status and urban rearing are as-
sociated with increased psychosocial stress, leading to
higher cortisol plasma levels,196,197 which are known to
diminish NMDAR-mediated synaptic plasticity.169 Sim-
ilarly, perinatal exposure to T. gondii and viral agents,
which are more prevalent during winter and spring, might
trigger a shift in the balance of type I/type II immunolog-
ical responses with an increase in proinflammatory cyto-
kines (eg, interleukin-1 and interleukin-18) that are
known to reduce NMDAR-dependent LTP.172,173,175 Im-
portantly, even a transient diminution of NMDAR func-
tion during early development can lead to various and
lasting cognitive deficits such as those seen in schizophre-
nia.198 Finally, in relation to cannabis use, there is strong
experimental evidence that endocannabinoids produced
by neurons or glia interact with NMDARs to mediate
several forms of transient and persistent synaptic plastic-
ity.199,200 ‘‘Given the widespread role of CB1 receptors
and endocannabinoids in eliciting or shaping neuronal
plasticity, it is reasonable to speculate that THC and
other cannabinoids produce their psychoactive effects
by perturbing endocannabinoid-mediated plasticity.’’201
6. While antipsychotics can lead to immediate improve-
ment for some individuals, the time course of medication
effects varies widely with some patients showing
responses to medication more than a month after begin-
ning treatment.
This point is related to the interpatient variability in
treatment response described by point 4 above. Both
points are consistent with the notion embodied by the
dysconnection hypothesis that distinct impairments in
the modulation of NMDAR-mediated synaptic plasticity
define distinct subgroups of patients. From this view, dif-
ferent time courses of the therapeutic response could be
explained by pathophysiology differences across patients.
Such differences could occur along various dimensions.
One example is that the time scale of plasticity required
to achieve therapeutic changes may differ across patients.
The early and late improvement seen with antipsychotics
speaks to the dual role of neuromodulatory transmitters
in terms of shaping (1) short-term synaptic plasticity
resulting in fast changes in postsynaptic responses and
(2) long-term synaptic plasticity leading to a lasting
reconfiguration of neuronal connections. Symptom im-
provement will therefore depend on whether immediate
changes in synaptic efficacy are sufficient (fast respond-
ers) or whether a lasting reshaping of neuronal circuitry
by experience-dependent plasticity is necessary to sup-
press symptoms (slow responders). An alternative view
is that different neuromodulatory actions may be im-
paired across patients. For example, in vivo receptor
PET studies showed that the level of striatal D2 receptor
occupancy predicted how quickly positive symptoms
responded to treatment with conventional antipsychotic
treatment by D2 antagonists: patients with high levels of
D2 receptor occupancy responded much more rapidly to
treatment than patients with normal levels of D2 receptor
occupancy.202 Based on these (and other) findings,
Laruelle et al85 hypothesized that in the former group
of schizophrenic patients the primary deficit might be
D2 receptor–induced NMDA hypofunction, whereas in
the latter group the positive symptoms might be driven
by an NMDA deficiency that was unrelated to DAergic
modulation. They argued that the therapeutic effect in
the latter group consists of setting D2 receptor stimula-
tion to below-normal levels and thus shifting the D1/D2
receptor ratio in favor of D1 receptors that promote
NMDAR-dependent signaling and plasticity.
7. Exposure to amphetamine, a DA agonist, can result in
schizophrenia-like symptoms in some individuals. This
effect may interact with liability, such that a single dose
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can trigger relapse in patients, butmore chronic use is usu-
ally needed to induce psychosis in low-risk populations.
And
8. A single exposure to phencycline and other NMDA re-
ceptor antagonists (such as ketamine) can result in
schizophrenia-like symptoms in some individuals.
Above, we have explained the occurrence of psychotic
experiences through a failure of self-monitoring, or cor-
ollary discharge, which results from a disturbance of
NMDA-dependent plasticity. Experimentally, psychotic
symptoms can be induced reliably by acute administra-
tion of NMDA antagonists in both healthy controls
and medication-free schizophrenic patients.40,67,203 Pre-
sumably, a certain threshold of NMDA dysfunction
must be reached before symptoms are manifest. Indeed,
previous experiments demonstrated that there is a buildup
of cognitive deficits with increasing ketamine dose,
with psychotic symptoms only being observed at
higher doses.204 Alternative, an indirect, and probably
slower, way of reaching a critical threshold of NMDA
dysfunction would be through changing neuromodula-
tory influences on NMDA-dependent synaptic plasticity.
For example, shifting the D1/D2 receptor activation
balance toward D2 receptor activation (eg, by amphet-
amine-induced hyperrelease of DA from midbrain
projections to the striatum),94,95,97,98 could reach the
critical threshold of NMDAR hypofunction over time
due to D2-evoked dampening of NMDAR-dependent
plasticity.191,192
9. In postmortem studies, pyramidal neurons in input
layers of prefrontal cortex have a reduced dendritic
spine density, whereas hippocampal neurons appear to
be abnormally oriented with signs of arrested migration.
The postmortem finding of reduced spine density has
been experimentally replicated across multiple studies
and various brain regions, including prefrontal cortex,
hippocampus, and sensorimotor cortex.73–76 As dis-
cussed above (see also Stephan et al25), this finding is per-
fectly consistent with chronic NMDA hypoactivation:
NMDAR activation is a potent promotor of dendritic
spine formation and dendritic growth.77–79 In contrast,
NMDAR blockade reduces spine density and dendritic
length.80–82 It is precisely this sort of change in spine den-
sity that is the consequence of abnormal synaptic plastic-
ity and speaks to dysconnection at a synaptic as opposed
to a cellular level (eg, due to a leukodystrophy or abnor-
mal cell migration).
An abnormal orientation of neurons in the hippocam-
pal formation (particularly the entorhinal cortex) and
occurrence of heterotopic cell clusters have also been
described by more than one study, although with some
inconsistencies with regard to the nature of the abnormal-
ity.205–207 In our opinion, it is therefore a less well-
established finding than the reduction of dendritic spine
density. Nevertheless, such an abnormal orientation due
to a presumed disturbance of neuronal migration during
development could also be explained by NMDA dysfunc-
tion. This is because NMDARs play an important role
during neuronal migration. In rodent studies, pharmaco-
logical blockade of NMDARs during development
strongly impairs neuronal migration, leading to abnor-
mally oriented pyramidal neurons and formation of het-
erotopic cell clusters in the cortex,208,209 ie,
cytoarchitectonic abnormalities that are similar to the
postmortem findings in schizophrenia described above.
10. GAD65 and 67, the rate-limiting enzymes that convert
glutamate to GABA, are reduced in schizophrenia
patients. Reelin, an important factor involved in syn-
aptic plasticity that colocalizes to GABAergic inter-
neurons, is also reduced.
There are theoretical accounts, most eloquently formu-
lated by Lewis and colleagues, which link the idea of
NMDAR-dependent dysconnectivity to empirically ob-
served pathologies of GABAergic neurons in schizophre-
nia. In particular, Lewis and Gonzalez-Burgos86 suggest
an elegant pathophysiological model of working memory
dysfunction in schizophrenia, explaining how a primary
NMDAR abnormality in the DLPFC can cause changes
in both GABAergic and DAergic function. Summarized
briefly, this model starts from the results of basic neuro-
anatomical and neurophysiological studies, which, as
explained above, show that the activity of DAergic mid-
brain neurons is controlled by glutamatergic projections
from prefrontal cortex.87,88,92 These prefrontal projec-
tions are regulated in strength through NMDAR-
dependent plasticity89–91 and target 2 different neuronal
populations in the midbrain: DAergic neurons that pro-
ject to the DLPFC (where their effects are mainly medi-
ated by D1 receptors) and GABAergic neurons in VTA.
Assuming that these interneurons dampen DAergic mes-
ostriatal projections,88,93 one can predict that hypofunc-
tion of NMDARs decreases prefrontal input to VTA,
resulting in reduced activity of GABAergic interneurons
in VTA and thus in increased activity of DAergic cells
projecting to the striatum (via D2 receptors); at the
same time, reduced prefrontal input to VTA decreases ac-
tivity of DAergic neurons projecting back to the DLPFC
(via D1 receptors). Both NMDA hypofunction and re-
duced D1-mediated signaling in DLPFC diminishes the
activity of (parvalbumin-positive) GABAergic neurons.
Because the expression of GAD65 and GAD67 is activity
dependent,210,211 this decrease in prefrontal GABAergic
activity may explain the reduced levels of GAD65 and
GAD67 messenger RNA levels that have been demon-
strated in postmortem studies in the DLPFC of schizo-
phrenic patients (for review, see Lewis et al212).
Supportive evidence for this comes from a recent rodent
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study by Homayoun and Moghaddam,213 which found
that NMDARs preferentially drive the activity of
GABAergic interneurons in PFC, rather than that of ex-
citatory pyramidal cells.
From a theoretical perspective, the projections from
prefrontal cortex to DAergic midbrain neurons are cen-
tral to the dysconnection hypothesis: ‘‘The ability of
events to elicit activity in ascending modulatory systems
will be determined by the inputs (afferents) to the cells of
origin of these systems (e.g., the VTA for DA or the nu-
cleus basalis for ACh). These afferents therefore deter-
mine what is valuable. How that valuable state is
achieved depends on selective consolidation of adaptive
responses to salient stimuli (e.g., conditioned responses to
appetitive stimuli) dictated by discharges in the ascending
systems.’’24 This means that if NMDAR-dependent plas-
ticity of projections to DA neurons is under dysfunc-
tional DA control, the schizophrenic brain may not be
able to represent salient or valuable stimuli, let alone re-
spond to them adaptively.
Concerning the second aspect of this point, reelin is
a signaling protein that was originally described as an im-
portant regulator of neuronal migration in the cortex
during development.214 More recently, it has become
clear that reelin also has important functions in the adult
brain where it takes part in the regulation of synaptic
plasticity.215 In particular, reelin is a potent enhancer
of NMDAR-dependent synaptic plasticity.216 A reduced
expression of reelin, as found in postmortem studies of
schizophrenia,217,218 would therefore lead to reduced
NMDAR-mediated synaptic plasticity.
From Dysconnectivity to Model-Based Diagnostics
In this article, we have described a pathophysiological
framework for schizophrenia, which explains both the
neurobiological causes of dysconnection, ie, abnormal
functional integration, and how dysconnectivity gives
rise to pathognomonic symptoms of schizophrenia. At
the neurophysiological level, we have reviewed evidence
that dysconnectivity results from a disturbance of
NMDAR-dependent synaptic plasticity due to abnormal
regulation by neuromodulatory transmitters. In an at-
tempt to bridge neurophysiological and cognitive levels,
we have described how this could lead to a fundamental
failure of self-monitoring (or corollary discharge) and
how the latter could explain some key clinical symptoms
of schizophrenia. Finally, we have demonstrated, point
by point, that our pathophysiological model of schizo-
phrenia has good explanatory power, accounting for
the majority of the empirical facts compiled by the editors
of this special issue.
The model of schizophrenia that is most closely related
to ours is probably that of Lewis and Gonzalez-Burgos.86
Anatomically, this model is concerned principally with
the DLPFC and, at a cognitive level, focuses on explain-
ing working memory dysfunction in schizophrenia. The
strength of this model is that by proposing a single pri-
mary mechanism, ie, hypofunction of NMDARs in the
DLPFC, it can account for a large range of empirically
established abnormalities of DAergic and GABAergic
function in the DLPFC. This model gives a precise ac-
count of the downstream effects that NMDAR dysfunc-
tion in prefrontal cortex can be expected to have on other
transmitter systems. However, it overlooks the fact that
a primary deficit in NMDAR-dependent plasticity would
not be limited to the DLPFC working memory system. In
contrast, the dysconnection hypothesis proposes that the
pathophysiological mechanism is not an isolated impair-
ment of NMDAR-dependent plasticity per se but an im-
pairment of NMDAR interaction with and regulation by
modulatory neurotransmitters like DA, ACh, and 5-HT.
This is a subtle but important difference: while it is pos-
sible that the etiological basis of this abnormal interac-
tion may reside in a genetically predetermined (and
environmentally unmasked) dysfunction of (1) the
NMDAR, (2) the receptor(s) of neuromodulatory trans-
mitter(s), or (3) the multiple signal transduction path-
ways that link the former 2, the pathophysiological
mechanism proposed by the dysconnection hypothesis
is a selective expression of NMDAR dysfunction in sit-
uations that require regulation of NMDAR-dependent
plasticity by neuromodulatory transmitters. This notion
distinguishes it from other pathophysiological theories of
schizophrenia that focus on impairments in NMDAR
function per se.40–44 Furthermore, the dysconnection hy-
pothesis is a functional hypothesis, formulated under spe-
cific theories of perceptual inference and learning. This is
important because it ties putative pathophysiological
mechanisms to the symptoms and signs of schizophrenia.
Finally, it is noteworthy that the notion of dysfunctional
interactions between NMDARs and neuromodulatory
receptors increasingly moves into the focus of current
pathophysiological theories and drug development
strategies.32,191,219–221
A specific prediction of the dysconnection hypothesis is
that perceptual, procedural (motor), and emotional (re-
inforcement) learning, all of which are known to require
neuromodulation of NMDARs, should induce abnormal
synaptic plasticity in schizophrenic patients. This article
has described several examples supporting this predic-
tion, eg, impaired perceptual learning in schizophrenia
(modulated by ACh and 5-HT57,58), aberrant procedural
learning (modulated by DA59), and abnormal reinforce-
ment learning (modulated by DA62,63,136). Experimen-
tally, one would test the dysconnection hypothesis by
pharmacological challenges that manipulate neuromodu-
latory influences on NMDAR-mediated plasticity during
the above types of learning: if one could establish that
these modulatory influences are unimpaired in schizo-
phrenic patients, the dysconnection hypothesis would
be refuted.
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Another important prediction by the dysconnection
hypothesis is that subgroups of patients should be distin-
guished by distinct patterns of impairments in the regu-
lation of NMDAR-dependent plasticity. This perspective
accounts for both uniformity and diversity across
patients: multiple neuromodulatory processes can, inde-
pendently or jointly, impact on the same pathophysiolog-
ical ‘‘bottleneck,’’ the plasticity mediated by NMDARs;
and this influence can be modulated by hormonal, met-
abolic, and immunological factors. In turn, these factors
can be induced by environmental influences (eg, psycho-
social stress, drugs, and infections). This view is consis-
tent with the facts that (1) the clinical spectrum of
schizophrenia is characterized by heterogeneous cogni-
tive symptoms that combine with a core of psychotic
symptoms, (2) patients show different therapeutic
responses to pharmacological treatment, and (3) genetic
studies have demonstrated the polygenetic nature of
schizophrenia.
Based on this view, one of the challenges will be to de-
velop methods for delineating patient subgroups that are
physiologically defined through one or several specific
impairments in NMDAR-dependent plasticity and their
regulation by DA, ACh, or 5-HT. As outlined previ-
ously,25 our own work aims to establish model-based di-
agnostic procedures that can provide such classifications.
The basic idea is to construct physiologically plausible
models of neuronal pathophysiology that can be fitted
to noninvasive brain data (eg, fMRI, EEG, and MEG)
and then use the estimated model parameters for diagnos-
tic classification. This is not dissimilar to established
approaches in internal medicine. For example, decades
of research on hypertension have yielded patho-
physiological models, which have established diagnostic
procedures that are in everyday use for detecting patient-
specific causes of high blood pressure (eg, measures of
hormone concentrations or renal blood flow). More re-
cently, cardiovascular research progressed toward bio-
physical and mechanistic models that can be fitted to
measurements of individual patients.222
Using dynamic causal modeling,223–228 we are cur-
rently working on models for inferring synaptic plasticity
from fMRI and EEG/MEG data, acquired during learn-
ing and decision-making tasks. For example, we have re-
cently established a dynamic causal model (DCM) that
infers, given measured fMRI data, how prediction errors
during incidental learning of audio-visual associations
drive plasticity of connections between auditory and vi-
sual areas.229 Similarly, we have established an EEG-
based DCM of plasticity during the MMN,230 which,
as described above, can be treated as a prediction error
signal during sensory learning that is known to be re-
duced in schizophrenia. We recently obtained some pre-
liminary construct validation of a DCM for spectral
responses using local field potentials recordings in rats
and microdialysis measures of extracellular glutamate.226
Similarly, in ongoing rodent studies using a within-
animal pharmacological design (with specific agonists
and antagonists of the same receptor), we are currently
testing the ability of DCM to detect the functional status
of particular neurotransmitter receptors and their in-
volvement in learning-induced plasticity. If successful,
such DCMs could then be used in clinical studies (eg,
using pharmacological challenges) to subdivide schizo-
phrenic patients into physiologically defined groups on
the basis of these receptor function indices. The advan-
tage of this approach is that the grouping of patients
is not simply driven by data but is constrained by a prin-
cipled and carefully specified theory. This model-based
approach reduces the effects of sampling variations
and other kinds of statistical noise and enhances the
chances of identifying the fundamental pathophysiolog-
ical dimensions of the schizophrenia spectrum.
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